tiprankstipranks
Trending News
More News >
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market
Advertisement

Kazia Therapeutics (KZIA) Ratios

Compare
321 Followers

Kazia Therapeutics Ratios

KZIA's free cash flow for Q2 2025 was AU$1.00. For the 2025 fiscal year, KZIA's free cash flow was decreased by AU$ and operating cash flow was AU$-420.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
0.21- 0.24 1.42 1.62
Quick Ratio
0.21- 0.24 1.93 1.62
Cash Ratio
0.19- 0.06 0.69 1.57
Solvency Ratio
-1.00- -0.79 -1.16 -1.40
Operating Cash Flow Ratio
-0.45- -0.37 -2.00 -4.86
Short-Term Operating Cash Flow Coverage
-52.98- -15.11 -8.44 -12.36
Net Current Asset Value
AU$ -18.31M-AU$ -25.46MAU$ -5.26MAU$ -8.71M
Leverage Ratios
Debt-to-Assets Ratio
<0.01- 0.03 0.06 0.05
Debt-to-Equity Ratio
-0.04- -0.06 0.15 0.10
Debt-to-Capital Ratio
-0.04- -0.07 0.13 0.09
Long-Term Debt-to-Capital Ratio
0.00- 0.00 0.00 0.00
Financial Leverage Ratio
-4.70- -2.15 2.33 1.88
Debt Service Coverage Ratio
-163.40- -41.79 -12.55 -12.56
Interest Coverage Ratio
0.00- 0.00 0.00 -12.75K
Debt to Market Cap
0.03- 0.08 0.56 0.23
Interest Debt Per Share
0.17- 1.32 0.97 1.39
Net Debt to EBITDA
0.13- 0.04 0.15 0.23
Profitability Margins
Gross Profit Margin
100.00%-100.00%100.00%100.00%
EBIT Margin
-973.57%--1240.68%-4350725.59%-101536916.00%
EBITDA Margin
-917.33%--1159.71%-4013885.95%-94059236.00%
Operating Profit Margin
-580.77%--1233.19%-4346661.08%-106785308.00%
Pretax Profit Margin
-575.40%--1171.97%-3736265.23%-100063580.00%
Net Profit Margin
-930.18%--1160.23%-3687419.82%-98591260.00%
Continuous Operations Profit Margin
-935.62%--1160.23%-3687419.82%-100056220.00%
Net Income Per EBT
161.66%-99.00%98.69%98.53%
EBT Per EBIT
99.08%-95.04%85.96%93.71%
Return on Assets (ROA)
-129.42%--124.06%-72.87%-70.51%
Return on Equity (ROE)
335.37%-267.33%-169.83%-132.24%
Return on Capital Employed (ROCE)
-1034.15%-675.74%-117.56%-88.18%
Return on Invested Capital (ROIC)
-948.54%-787.50%-109.52%-81.91%
Return on Tangible Assets
-672.57%--432.95%-189.22%-165.32%
Earnings Yield
-291.13%--342.80%-637.93%-305.87%
Efficiency Ratios
Receivables Turnover
28.18- 17.35 0.91 <0.01
Payables Turnover
0.00- 0.00 0.00 0.00
Inventory Turnover
0.00- 0.00 0.00 0.00
Fixed Asset Turnover
0.00- 0.00 0.00 0.00
Asset Turnover
0.14- 0.11 <0.01 <0.01
Working Capital Turnover Ratio
-0.15- -0.28 <0.01 <0.01
Cash Conversion Cycle
12.95- 21.03 401.17 744.60K
Days of Sales Outstanding
12.95- 21.03 401.17 744.60K
Days of Inventory Outstanding
0.00- 0.00 0.00 0.00
Days of Payables Outstanding
0.00- 0.00 0.00 0.00
Operating Cycle
12.95- 21.03 401.17 744.60K
Cash Flow Ratios
Operating Cash Flow Per Share
-8.77- -19.98 -8.22 -17.18
Free Cash Flow Per Share
-8.77- -19.98 -8.22 -17.18
CapEx Per Share
0.00- 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00- 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00- 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00- 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-52.98- -15.11 -8.44 -12.36
Operating Cash Flow to Sales Ratio
-2.99- -4.15 -27.31K -910.44K
Free Cash Flow Yield
-138.42%--122.65%-47.24%-28.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.34- -0.29 -0.16 -0.33
Price-to-Sales (P/S) Ratio
2.16- 3.38 5.78K 322.34K
Price-to-Book (P/B) Ratio
-2.09- -0.78 0.27 0.43
Price-to-Free Cash Flow (P/FCF) Ratio
-0.72- -0.82 -0.21 -0.35
Price-to-Operating Cash Flow Ratio
-1.07- -0.82 -0.21 -0.35
Price-to-Earnings Growth (PEG) Ratio
-0.01- 0.00 <0.01 >-0.01
Price-to-Fair Value
-2.09- -0.78 0.27 0.43
Enterprise Value Multiple
-0.11- -0.25 0.01 -0.11
Enterprise Value
2.46M- 6.79M 28.64M 75.06M
EV to EBITDA
-0.11- -0.25 -1.29 -3.19
EV to Sales
0.99- 2.94 51.60K 3.00M
EV to Free Cash Flow
-0.33- -0.71 -1.89 -3.30
EV to Operating Cash Flow
-0.33- -0.71 -1.89 -3.30
Tangible Book Value Per Share
-21.49- -53.00 -2.83 -1.07
Shareholders’ Equity Per Share
-4.48- -20.89 6.54 14.07
Tax and Other Ratios
Effective Tax Rate
>-0.01- 0.01 -0.01 0.01
Revenue Per Share
2.93- 4.81 <0.01 <0.01
Net Income Per Share
-27.26- -55.83 -11.11 -18.61
Tax Burden
1.62- 0.99 0.99 0.99
Interest Burden
0.59- 0.94 0.86 0.99
Research & Development to Revenue
6.10- 7.53 28.04K 810.09K
SG&A to Revenue
4.64- 5.88 15.46K 180.46K
Stock-Based Compensation to Revenue
0.13- 0.23 2.09K 67.00K
Income Quality
0.32- 0.36 0.74 0.92
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis